Factor Vii Use in Cabg Patients

Canadian Journal of Anaesthesia - United States
doi 10.1007/bf03017070
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Use of Recombinant Factor VII in Cardiac Surgery

Recent Patents on Cardiovascular Drug Discovery
2012English

CABG Versus CABG+TMR in Patients With and Without Advanced CAD

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2015English

Intraoperative Use of Recombinant Activated Factor VII During Complex Aortic Surgery

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2012English

Recombinant Activated Factor VII (rFVIIa) Treatment of Refractory Bleeding in Cardiac Surgical Patients

Journal of Anesthesia & Clinical Research
2012English

Preemptive Use of Recombinant Activated Factor VII: Many Questions but Few Answers

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2006English

Potential Thrombogenic Complications With the Use of Recombinant Activated Factor VII in Combat Trauma

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2007English

Elective Surgery on Factor VIII Inhibitor Patients Using Continuous Infusion of Recombinant Activated Factor VII

Thrombosis and Haemostasis
Hematology
2001English

Positron Emission Tomography; Viable Tool in Patients Pre-Cabg?

International Journal of Cardiovascular Imaging
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2010English

Analysis of the Off-Licence Use of Recombinant Activated Factor VII for Patients With Uncontrolled Haemorrhage in a UK Tertiary Referral Hospital

Critical Care
Critical CareIntensive Care Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy